Ocaliva Liver Injury Lawsuits

Legal Representation for Victims of Ocaliva-Related Liver Damage

At Rafferty Domnick Cunningham & Yaffa, we are dedicated to representing individuals and families harmed by dangerous pharmaceutical drugs. One such drug currently under intense legal and medical scrutiny is Ocaliva (generic name: obeticholic acid), a treatment for Primary Biliary Cholangitis (PBC) that has been linked to serious and potentially fatal liver injuries.

If you or someone you care about took Ocaliva and later developed serious liver injuries, cirrhosis, hepatic failure, or died from liver complications, you may qualify for representation. Our nationally respected legal team is actively investigating claims and offering free case evaluations to those affected.

Understanding Ocaliva: What It Treats and How It Works

What Is Primary Biliary Cholangitis (PBC)?

Primary Biliary Cholangitis is a rare autoimmune condition in which the body gradually destroys the bile ducts in the liver, leading to inflammation, scarring, and eventual liver failure if untreated. Ocaliva was approved in 2016 to help manage PBC when patients did not respond to first-line therapy.

How Was Ocaliva Supposed to Help?

Ocaliva works by activating the farnesoid X receptor (FXR) in the liver, which is believed to reduce bile acid levels and slow disease progression. However, while the drug showed initial promise, post-marketing surveillance revealed a troubling trend of adverse liver events, including cases where patients developed cirrhosis or experienced liver decompensation after starting Ocaliva.

Safety Concerns and Regulatory Action

FDA Black Box Warning and U.S. Monitoring

In 2018, the U.S. Food and Drug Administration (FDA) issued a black box warning, the most serious type of warning label available, indicating that Ocaliva could cause serious and fatal liver injury, especially in patients with pre-existing liver conditions. The FDA also implemented strict monitoring protocols for liver function during treatment.

Ocaliva Removed from European Market

In 2024, the European Medicines Agency (EMA) revoked Ocaliva’s marketing authorization, effectively pulling the drug from shelves in the EU. The decision came after a comprehensive safety review revealed no positive risk-benefit ratio for patients, especially those with advanced liver disease. The European withdrawal has intensified scrutiny of Ocaliva’s safety profile in the United States.

Who May Be Eligible to File an Ocaliva Lawsuit?

Criteria for Lawsuit Eligibility: You may qualify for an Ocaliva lawsuit if:

  • You were prescribed Ocaliva for Primary Biliary Cholangitis
  • You developed new or worsened liver injury after using the drug, such as:
    • Cirrhosis
    • Liver fibrosis
    • Hepatic failure
    • Hospitalization or emergency care
  • You do not have an exclusionary pre-existing condition such as:
    • Hepatitis B or C
    • Alcohol-related liver disease/cirrhosis

Liver Damage Warning Signs

If you took Ocaliva for PBC, pay close attention to these warning signs as they may signal that liver damage is worsening:

  • Fatigue, jaundice, or skin yellowing: when bilirubin accumulates in the body, it can cause a yellow-appearance. This signals that the liver is not filtering bilirubin properly, indicating decreased liver function.
  • Abdominal swelling and pain: Pain from the liver most often occurs in the right upper abdomen. This pain may be dull, aching, a pressure sensation. When combined with bloating or nausea, this can indicate inflammation or liver decompensation.
  • Elevated liver enzymes (ALT, AST, bilirubin
  • Worsening of previously stable liver function
  • Dark Urine: dark urine suggests it contains excess bilirubin, indicating the liver is not clearing it properly.
  • Severe or worsening itching: the FDA has stated the new or significantly worsening itching can be a symptom of worsening liver injury.
  • Fatigue or weakness: sudden or severe exhaustion can be a red flag for liver decline. If this exhaustion accompanies appetite loss, confusion, fever, or weight loss, it may be due to your liver’s failure to clear toxins and maintain your metabolism.

Manufacturer Liability: What Did Intercept Pharmaceuticals Do Wrong?

Allegations in Ocaliva Legal Claims

Patients and their families are pursuing claims based on the following allegations:

  • Failure to Warn: The manufacturer did not issue adequate or timely warnings to doctors or patients about the full extent of the risks.
  • Negligent Marketing: Ocaliva was aggressively marketed to a broader patient base than intended, including those with advanced liver disease, which the drug was not proven safe for.
  • Delayed Safety Response: Even after evidence of harm emerged, the company failed to act swiftly or transparently.

These failures may constitute negligence, product liability, and failure to warn—all of which are grounds for legal action.

Injured and Have 
Questions?

Call us or request a case review by our experts.

RDCY law firm shareholders

How Rafferty Domnick Cunningham & Yaffa Helps Clients Injured by Ocaliva

At Rafferty Domnick Cunningham & Yaffa, we understand that contacting a law firm after a serious medical injury can feel overwhelming. You may be dealing with health complications, financial strain, and the emotional toll of betrayal by a pharmaceutical company you trusted. Our role is to remove that burden from your shoulders and become your dedicated advocate—every step of the way.

We offer more than legal representation. We provide guidance, clarity, and the full strength of our experience in complex pharmaceutical litigation. Here’s how we help clients harmed by Ocaliva:

Free, Confidential Case Evaluation

The first step is easy—and free. We’ll listen to your story, review your medical history, and determine if your case meets the criteria for an Ocaliva-related lawsuit. You don’t need to have all your records in hand. Our intake team and attorneys will help gather and assess the documents we need.

Thorough Medical & Legal Investigation

Once we accept your case, our attorneys work closely with medical experts to analyze your liver test results, diagnosis timeline, and treatment history. We identify whether Ocaliva use directly contributed to or worsened your liver injury—and whether your doctor was adequately warned by the manufacturer. This evidence is crucial to holding the drugmaker accountable.

Building a Strong Legal Claim

Our team prepares your claim using the same level of rigor and detail we bring to every high-stakes litigation matter. We collect and present medical records, witness testimony, expert analysis, and regulatory evidence to prove that the manufacturer failed in its legal duty to warn, protect, and test properly.

Navigating Mass Tort or Individual Litigation

Depending on your circumstances, we may file your claim as part of a mass tort lawsuit, where multiple victims seek justice for similar injuries caused by Ocaliva, or as an individual product liability lawsuit tailored specifically to your case. We’ll explain your options clearly and help you choose the best legal path.

No Upfront Costs – You Only Pay If We Win

We work on a contingency fee basis, meaning you pay nothing unless we recover compensation for you. We believe everyone should have access to justice—regardless of their financial situation. You don’t have to worry about hourly rates, legal fees, or unexpected costs.

Compassionate, Client-Centered Support

You are more than a case file. Our attorneys and staff will treat you with respect, compassion, and dignity throughout the legal process. We’ll keep you informed, answer your questions, and always prioritize your best interests. Many of our clients are managing serious health issues, and we take pride in being a source of both legal strength and personal support.

How to Prepare for an Ocaliva Lawsuit

Documentation You Will Need

If you are considering legal action, it helps to gather the following:

  • Proof of Ocaliva prescription, including dates and dosage
  • Medical records, including liver function tests, imaging, and liver biopsy results
  • Treatment notes from your hepatologist or primary care doctor
  • Hospital records if you were admitted for liver-related issues
  • Documentation that rules out other liver disease causes, such as Hepatitis or alcohol abuse

Our firm can help you collect and review these materials as part of your intake. Even if you do not have every document available, we will work with your healthcare providers to build your case.

What Compensation May Be Available?

Patients harmed by Ocaliva may be eligible for significant compensation, which could include:

  • Medical expenses (past and future)
  • Lost wages and loss of earning capacity
  • Pain and suffering
  • Emotional distress
  • Wrongful death damages for surviving family members
  • Punitive damages, if misconduct by the manufacturer is proven

Compensation is awarded based on the specific facts of each case, including the severity of the injury and its impact on the victim’s life.

Nationwide Representation for Ocaliva Victims

We are actively investigating Ocaliva injury claims across the United States. Whether you’re in Florida, California, New York, Texas, or another state, Rafferty Domnick Cunningham & Yaffa has the experience and resources to represent your case.

Our team will:

  • Conduct a free, confidential case review
  • Help you gather and evaluate your medical evidence
  • Explain your legal options in clear, compassionate language
  • Handle all communications with the drug manufacturer and insurers
  • Aggressively pursue compensation on your behalf

Frequently Asked Questions About Ocaliva Liver Injury Lawsuits

What is Ocaliva, and who manufactured it?

Ocaliva is the brand name for obeticholic acid, a prescription medication approved to treat Primary Biliary Cholangitis (PBC), a chronic autoimmune liver disease. The drug was originally developed and marketed by Intercept Pharmaceuticals and later acquired by Alfasigma. Lawsuits allege that the manufacturer failed to adequately warn patients and doctors about serious liver injury risks associated with the drug.

Why is Ocaliva considered a dangerous drug?

Ocaliva is considered dangerous because post-approval data revealed it could cause or worsen liver damage, even when prescribed as directed. Patients reported developing cirrhosis, liver failure, and other severe complications. In some cases, injuries occurred despite routine liver monitoring, suggesting the drug itself posed inherent risks that were not fully disclosed at the time of approval.

What did the FDA say about Ocaliva?

In 2018, the U.S. Food and Drug Administration (FDA) issued a black box warning—the strongest safety warning available—after reports of serious liver injury and deaths. The FDA warned that Ocaliva could cause severe and potentially fatal liver damage, particularly in patients with advanced liver disease or cirrhosis.

The warning stressed the importance of frequent liver test monitoring and immediate discontinuation if there was evidence of liver decline or impairment.

Why was Ocaliva removed from the European market?

In 2024, the European Medicines Agency (EMA) withdrew Ocaliva’s approval after determining that the drug did not provide sufficient benefit to outweigh its risks. The decision followed a comprehensive review of safety and effectiveness data. The EU withdrawal has become a key point of concern in U.S. litigation, as the drug remains available domestically.

If Ocaliva is still sold in the U.S., can I still bring a lawsuit?

Yes. A drug does not need to be recalled for lawsuits to be valid. Many pharmaceutical injury lawsuits involve drugs that remain on the market but are later shown to have caused harm due to inadequate warnings, defective design, or improper marketing.

Injured and Have 
Questions?

Call us or request a case review by our experts.

RDCY law firm shareholders

Contact Rafferty Domnick Cunningham & Yaffa Today

You trusted a prescription drug to help you manage a chronic condition. You weren’t warned that it might leave you with worsened liver disease, a need for transplant, or a lifelong medical condition. You are not alone—and you may have legal options.

Contact Rafferty Domnick Cunningham & Yaffa today to schedule a free consultation with our experienced defective drug attorney. We do not charge any fees unless we win compensation for you.

Let us help you move forward with knowledge, power, and the legal support you deserve.

Explore More